Ads
related to: 4 phases of clinical trials
Search results
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 6 days agoThe CheMo4METPANC trial is evaluating the company's CXCR4 inhibitor motixafortide, the PD-1...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
Morning Times· 3 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 16 hours agoThere are currently no approved therapies for the treatment of bronchiectasis. All treatments for...
Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024
Pharmaceutical Technology via Yahoo Finance· 13 hours agoThe involvement of two optimistic agents to tackle symptoms and exacerbations as a fixed-dose...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 2 days agoDepressive Disorder: Results From the Phase 2, Proof-of-Concept X-NOVA Study” May 29, 2024 at 11:15 am to 1 pm ET in Salon 4 The Company ...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 6 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoTILT Biotherapeutics will present these findings at the American Society of Clinical Oncology (ASCO)...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 14 hours agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
Morningstar· 15 hours agoSOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for ...
Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Clinical Trials Arena via Yahoo Finance· 7 days agoThe subjects will receive either long-course chemoradiation (LCCRT) or short-course radiotherapy...
